Effect of ciprofloxacin on the proliferation of osteoblast-like MG-63 human osteosarcoma cells in vitro

Journal of Orthopaedic Research

Volumn 16, Issue 4, 1998, Pages 509-512

  Miclau, T ^a   Edin, M L ^a   Lester, G E ^a   Lindsey, R W ^a   Dahners, L E ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BONE; DRUG DOSAGE;

CIPROFLOXACIN;

ANIMAL CELL CULTURE;

CIPROFLOXACIN;

ANTIBIOTIC THERAPY; ARTICLE; BONE LEVEL; CELL COUNT; CELL PROLIFERATION; CONCENTRATION RESPONSE; DNA SYNTHESIS INHIBITION; DOSE RESPONSE; DRUG EFFECT; HUMAN; HUMAN CELL; OPEN FRACTURE; OSTEOBLAST; OSTEOMYELITIS; OSTEOSARCOMA CELL; PRIORITY JOURNAL;

EID: 0032124582     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100160417     Document Type: Article

References (26)

1. 1 Adams K, Couch L, Cierny G, Calhoun J, Mader JT: In vitro and in vivo evaluation of antibiotic diffusion for antibiotic‐impregnated polymethylmethacrylate beads. Clin Orthop 278: 244–252, 1992
2. 2 Atkinson BA: Species incidence and trends of susceptibility to antibiotics in the United States and other countries: MIC and MBC. In: Antibiotics in Laboratory Medicine, ed 2, pp 1122–1141. Baltimore, Williams and Wilkins, 1986
3. 3 Beeching NJ, Thomas MG, Roberts S, Lang SDR: Comparative in vitro activity of antibiotics incorporated in acrylic bone cement. J Aruimicrob Chemother 17: 173–184, 1986
4. 4 Bergan T: Extravascular penetration of ciprofloxacin. Diagn Microbiol Infect Dis 13: 103–114, 1990
5. 5 Buchholz HW, Englebrecht H: Uber die Depotwirkung einiger Antibiotika bei vermischung unter den Kunstharz Palacos. Chirurg 41: 511–515, 1970
6. 6 Chao W, Lin SS, Charleton WH, Shah SA, Tuan RS: Biodegradable drug delivery system applied onto fracture fixation plates and intramedullary rods: in vivo comparative analysis. Trans Orthop Res Soc 20: 299, 1995
7. 7 Clawson DK, Davis FJ, Hansen ST: Treatment of chronic osteomyelitis with emphasis on closed suction‐irrigation technic. Clin Orthop 96: 88–97, 1973
8. 8 Clover J, Gowen M: Are MG‐63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? Bone 15: 585–591, 1994
9. 9 DiMaio FR, O'Halloran JJ, Quale JM: In vitro elution of ciprofloxacin from polymethylmethacryiate cement beads. J Orthop Res 12: 79–82, 1994
10. 10 Hussy P, Maass G, Tummler B, Grosse F, Schomburg U: Effect of 4‐quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II growth of mammalian lymphoblasts. Antimicrob Agents Chemother 29: 1073–1078, 1986
11. 11 Klemm KW: Antibiotic bead chains. Clin Orthop 295: 63–76, 1993
12. 12 Lawrence JW, Darkin‐Rattray S, Xie F, Neims AH, Rowe TC: 4‐Quinolones cause a selective loss of mitochondria DNA from mouse L1210 leukemia cells. J Cell Biochem 51: 165–174, 1993
13. 13 Levin PD: The effectiveness of various antibiotics in methyl methacrylate. J Bone Joint Surg [Br] 57: 234–237, 1975
14. 14 Lin SS, Shah S, Fitzpatrick M, Tuan R: Treatment of open fractures with intramedullary rods coated with an antibiotic‐impregnated biodegradable drug delivery system. Trans Orthop Res Soc 19: 292, 1994
15. 15 Lin SS, Sinha RK, Shah SA, Tuan RS: Analysis of human osteoblast metabolism after antibiotic treatment in vitro. Trans Orthop Res Soc 20: 260, 1995
16. 16 Mader JT, Cierny G III: The principles of the use of preventive antibiotics. Clin Orthop 190: 75–82, 1984
17. 17 McLaren AC, Miniaci A: In vivo study to determine the efficacy of cancellous bone graft as a deliver vehicle for antibiotics. Trans Soc Biomater 12: 102. 1986
18. 18 Miclau T, Edin ML, Lester GE, Lindsey RW, Dahners LE: Bone toxicity of locally applied aminoglycosides. J Orthop Trauma 9: 401–406, 1995
19. 19 Miyano JA, Ramchandani M, Robinson DH, Radio SJ, Garvin KL: Bone penetration of ciprofloxacin delivered locally by biodegradable PLGA implants. Orthop Trans 18: 1075, 1994
20. 20 Perry CR, Rice S, Ritterbusch JK, Burdge RE: Loc administration of antibiotics with an implantable osmotic pump. Clin Orthop 192: 284–290, 1985
21. 21 Smilack JD, Flittie WH, Williams TW, Jr: Bone concentrations of antimicrobial agents after parenterai administration. Anti microb Agents Chemother 9: 169–71, 1976
22. 22 Teupe C, Meffert R, Winckier S, Ritzerfeld W, Tormala P, Brug E: Ciprofloxacin‐impregnated poly‐L‐lactic acid drug carrier: new aspects of a resorbable drug delivery system antimicrobial treatment of bone infections Arch OrthopTrauma Surg 112: 33–35, 1992
23. 23 Trippel SB: Current concepts review. Antibiotic impreganted cement in total joint arthroplasty. J Bone Joint Surg [Am] 68: 1297–1302, 1986
24. 24 Varlet A, Dauchy P: Billes de platre de Paris aux antibiotics dans le traitement de I'infection osseuse. Rev Chir Orthop 69: 239–244, 1983
25. 25 Wahlig H, Dingeldein E, Bergman R, Reuss K: The gentamic release of in from polymethylmethacrylate. J Bone Joint Surg[Br] 60: 270–275, 1978
26. 26 Wahlig H, Dingeldein E: Antibiotics and bone cements. Acta Orthop Scand 51: 49–56, 1980